Credit Suisse’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,207,200
| Closed | -$189M | – | 4144 |
|
|
2021
Q4 | $189M | Buy |
3,207,200
+779,700
| +32% | +$38.6M | 0.1% | 194 |
|
|
2021
Q3 | $104M | Sell |
2,427,500
-614,300
| -20% | -$27.2M | 0.06% | 357 |
|
|
2021
Q2 | $119M | Buy |
3,041,800
+1,147,300
| +61% | +$44.6M | 0.06% | 328 |
|
|
2021
Q1 | $68.6M | Sell |
1,894,500
-34,300
| -2% | -$1.22M | 0.04% | 573 |
|
|
2020
Q4 | $71M | Sell |
1,928,800
-535,136
| -22% | -$19.6M | 0.03% | 552 |
|
|
2020
Q3 | $85.8M | Buy |
2,463,936
+206,373
| +9% | +$7.24M | 0.05% | 394 |
|
|
2020
Q2 | $70M | Buy |
2,257,563
+362,049
| +19% | +$12.3M | 0.05% | 401 |
|
|
2020
Q1 | $58.7M | Buy |
1,895,514
+201,631
| +12% | +$6.87M | 0.05% | 378 |
|
|
2019
Q4 | $63M | Buy |
1,693,883
+441,731
| +35% | +$15.7M | 0.05% | 443 |
|
|
2019
Q3 | $42.7M | Buy |
1,252,152
+184,134
| +17% | +$6.7M | 0.04% | 533 |
|
|
2019
Q2 | $43.9M | Buy |
1,068,018
+127,745
| +14% | +$5.07M | 0.04% | 499 |
|
|
2019
Q1 | $37.9M | Buy |
940,273
+66,823
| +8% | +$2.68M | 0.03% | 534 |
|
|
2018
Q4 | $36.2M | Sell |
873,450
-7,905
| -0.9% | -$328K | 0.04% | 503 |
|
|
2018
Q3 | $36.9M | Buy |
881,355
+337,280
| +62% | +$13M | 0.03% | 553 |
|
|
2018
Q2 | $18.7M | Buy |
544,075
+52,279
| +11% | +$1.79M | 0.02% | 878 |
|
|
2018
Q1 | $16.6M | Sell |
491,796
-300,390
| -38% | -$10.3M | 0.02% | 964 |
|
|
2017
Q4 | $27.2M | Buy |
792,186
+507,606
| +178% | +$17.3M | 0.02% | 721 |
|
|
2017
Q3 | $9.64M | Buy |
284,580
+21,080
| +8% | +$678K | 0.01% | 1267 |
|
|
2017
Q2 | $8.4M | Sell |
263,500
-379,440
| -59% | -$12M | 0.01% | 1301 |
|
|
2017
Q1 | $20.9M | Sell |
642,940
-922,250
| -59% | -$29.1M | 0.02% | 809 |
|
|
2016
Q4 | $48.2M | Buy |
1,565,190
+484,840
| +45% | +$14.8M | 0.05% | 419 |
|
|
2016
Q3 | $34.7M | Sell |
1,080,350
-484,313
| -31% | -$16.2M | 0.03% | 584 |
|
|
2016
Q2 | $52.3M | Buy |
1,564,663
+1,443,453
| +1,191% | +$46.1M | 0.06% | 353 |
|
|
2016
Q1 | $3.41M | Sell |
121,210
-604,047
| -83% | -$17.3M | ﹤0.01% | 1792 |
|
|
2015
Q4 | $22.2M | Buy |
+725,257
| New | +$22.8M | 0.03% | 726 |
|
|
2015
Q3 | – | Sell |
-216,070
| Closed | -$6.87M | – | 4428 |
|
|
2015
Q2 | $6.87M | Sell |
216,070
-333,064
| -61% | -$10.9M | 0.01% | 1488 |
|
|
2015
Q1 | $18.1M | Buy |
549,134
+171,486
| +45% | +$5.45M | 0.02% | 862 |
|
|
2014
Q4 | $11.2M | Buy |
377,648
+181,077
| +92% | +$5.19M | 0.01% | 1202 |
|
|
2014
Q3 | $5.51M | Hold |
196,571
| – | – | ﹤0.01% | 1683 |
|
|
2014
Q2 | $5.54M | Buy |
196,571
+61,132
| +45% | +$1.74M | ﹤0.01% | 1871 |
|
|
2014
Q1 | $4.13M | Sell |
135,439
-179,075
| -57% | -$5.34M | ﹤0.01% | 1927 |
|
|
2013
Q4 | $9.14M | Sell |
314,514
-276,780
| -47% | -$8.06M | 0.01% | 1345 |
|
|
2013
Q3 | $16.1M | Sell |
591,294
-745,494
| -56% | -$20.3M | 0.02% | 864 |
|
|
2013
Q2 | $35.5M | Buy |
+1,336,788
| New | +$36.9M | 0.04% | 496 |
|
Other funds holding PFE
Credit Suisse's PFE Position: Q1 2024 in Review
Credit Suisse reduced its Pfizer (PFE) stake by 4% in Q1 2024, selling an estimated $10.1M and leaving 8,614,681 shares worth $239M. The position accounts for 0.23% of the portfolio, ranked #80.
Credit Suisse first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.39B in Q4 2014. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Credit Suisse held 8,614,681 shares of Pfizer worth $239M as of Q1 2024.
- Credit Suisse sold 363,142 Pfizer shares in Q1 2024, an estimated $10.1M.
- Pfizer made up 0.23% of Credit Suisse's portfolio in Q1 2024, its #80 holding.
- Credit Suisse first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Pfizer position peaked at $1.39B in Q4 2014.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.